Half-life profile
Alprazolam half-life calculator
Educational first-order elimination curve using an approximate half-life estimate. This is not medical advice and does not predict impairment or laboratory outcomes.
Category: benzodiazepine · Updated: 2026-01-18
Pharmacokinetics at a glance
| Summary | Educational half-life profile for Alprazolam (benzodiazepine). Uses a mean half-life of 12.0 hours for a simplified curve. |
|---|---|
| Mean half-life | 12 hours |
Summary: Educational half-life profile for Alprazolam (benzodiazepine). Uses a mean half-life of 12.0 hours for a simplified curve.
Half-life note: Mean terminal half-life reported in published pharmacokinetic studies. Values vary by population, dose, route, and analytic method.
Notes
Overview
Alprazolam is listed here as benzodiazepine. Benzodiazepines are central nervous system depressants used clinically for anxiety, seizures, and procedural sedation. Reported half-life can differ by formulation, population, and whether active metabolites contribute to the tail of the curve.
This page provides an educational visualization of exponential decay based on a single half-life estimate. It is not medical advice.
Half-life used on this page
HalfLifeDB uses a mean half-life of 12.0 hours to generate the curve below. The curve shows a relative amount remaining in a simplified model.
Half-life note: Mean terminal half-life reported in published pharmacokinetic studies. Values vary by population, dose, route, and analytic method.
What the curve represents
The calculator assumes a one-compartment, first-order elimination model after a single starting amount. In that model, the remaining amount halves every half-life interval. The curve is best used to understand the shape of exponential decline.
Why published half-life values differ
Even when a study reports a single half-life number, values can differ across studies and people. Common drivers include:
- Route and formulation: immediate vs extended release, oral vs inhaled vs injected, and co-administered ingredients.
- Study design: sampling window, analytic sensitivity, and how the terminal phase is defined.
- Individual biology: age, genetics, body composition, and liver and kidney function.
- Interactions: other medications and substances can inhibit or induce metabolism.
How to use this page
- Use the calculator to visualize how quickly a half-life process decays over time.
- Use the source links to see the context for the half-life estimate.
- Treat this curve as a conceptual model, not a personal prediction.
What this page does not do
- It does not provide dosing guidance or treatment advice.
- It does not estimate impairment or functional safety.
- It does not predict laboratory outcomes.
If you have questions about medication use or health decisions, consult a licensed clinician. In an emergency, contact local emergency services.
Read the full medical disclaimer and editorial policy.